In this community, professionals share information regarding the clinical, programmatic and community-oriented aspects of early diagnosis, treatment and prevention of multi-drug-resistant tuberculosis (MDR-TB). Members also use this forum to promote universal access to quality care for MDR-TB.

Community moderators

Masoud Dara, MD
WHO Europe - EURO
Christopher Gilpin, PhD, MPH
World Health Organization - WHO
Dylan Tierney
Brigham and Women's Hospital, Division of Global Health Equity

Recent discussion topics

Resource on pediatric TB

By Erica Lessem on 10 Feb, 2016 3 Replies

Dear colleagues, Some of you may be interested in a new resource available on pediatric TB. This new reference book from leading TB experts includes a chapter on DR-TB in children. See more details, below: The *Handbook of Child and Adolescent…

Surrogate outcomes

By Tom Yates on 07 Feb, 2016 4 Replies

Hello, I'd like to draw people's attention to an important paper just published by Patrick Phillips and colleagues... http://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0565-y The team reanalysed data from the REMoxTB trial, to assess how…

Fwd: FW: paper from STAT published in EID online

By Alaine Umubyeyi Nyaruhirira on 06 Feb, 2016 1 Reply

Dear all, Please see below link to an online publication from the DR STAT group on "Global Progress and Challenges in Implementing New Medications for Treating Multidrug-Resistant Tuberculosis" http://wwwnc.cdc.gov/eid/article/22/3/15-1430_article *Alaine…

New community members

User Photo

Zain Ali

Affiliated Organizations

Dow University of Health Sciences - DUHS

Work Locations

Pakistan

User Photo

Sarah Schwarzmann

Affiliated Organizations

Greater Baltimore Medical Center

Work Locations

United States

User Photo

Melissa Correia

Affiliated Organizations

University of Massachusetts Boston

Work Locations

United States